| Fixed Assets Sr Specialist |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Buyer LACan (Temporary) |
INSURGENTES |
Mexico |
Operations |
CTS |
Procurement |
15 September 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 May 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 May 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
22 October 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 May 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 May 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
20 May 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
17 July 2024 |
| (高级)地区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
21 June 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 June 2024 |
| (高级)医药代表 /(资深)产品专员 |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
01 July 2024 |
| (高级)医药代表 /(资深)产品专员 |
Zhanjiang (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
01 July 2024 |
| Lead, Medical Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
02 July 2024 |
| County Executive |
Longyan (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
04 July 2024 |
| 县域主任/县域主管 |
Dazhou (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
04 July 2024 |
| Senior District Manager |
Zhanjiang (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
05 July 2024 |
| Lead, RWE and Evidence Excellence |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
10 July 2024 |
| DM |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
18 July 2024 |
| Senior Statistical Programmer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
18 July 2024 |
| QC Analyst |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
03 September 2024 |
| MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
22 July 2024 |
| Associate/Manager, MSL(Oncology) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
22 July 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 July 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
28 July 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
28 July 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
30 July 2024 |
| Solution Design |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
03 September 2024 |
| MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
05 August 2024 |
| Senior/Advanced Medical/Sales Representative |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Sales |
06 August 2024 |
| Product Specialist |
Jingzhou (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
06 August 2024 |
| Associate/Manager, MSL (Cardiovascular) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
20 August 2024 |
| Medical Field Trainer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
29 August 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
30 August 2024 |
| MR |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Sales |
01 September 2024 |
| Study Leader |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
05 September 2024 |
| Group Manager, MSL |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Research & Development |
05 September 2024 |
| 县域主任/县域主管 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
10 September 2024 |
| Japan Program Clinical Head (IMM) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Biomedical Research |
Innovative Medicines |
Research & Development |
10 September 2024 |
| MR |
Pingxiang (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
23 September 2024 |
| District Manager |
Haerbin (Heilongjiang Province) |
China |
International |
Innovative Medicines |
Sales |
24 September 2024 |
| (高级)地区经理 |
Bozhou (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
24 September 2024 |
| (高级)医药代表 /(资深)产品专员 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
24 September 2024 |
| 县域主任(主管) |
Luoyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
26 September 2024 |
| (高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
29 September 2024 |
| Therapy Area Partner |
Abha |
Saudi Arabia |
International |
Innovative Medicines |
Sales |
01 October 2024 |
| TA Strategy Lead - GenMed |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
02 October 2024 |
| CX strategy |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
04 October 2024 |
| Medical Content Lead (m/w/d), Hematology |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Research & Development |
09 September 2024 |
| 县域主任/县域主管 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
10 September 2024 |